WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its financial results for the first quarter of fiscal year 2013 will be released after the market close on Thursday, November 8, 2012, followed the same day by a conference call and live webcast scheduled for 4:30 p.m. ET.
